Please login to the form below

Not currently logged in
Email:
Password:

abemaciclib

This page shows the latest abemaciclib news and features for those working in and with pharma, biotech and healthcare.

Eli Lilly demonstrates Verzenio win in high-risk breast cancer subset at ASCO

Eli Lilly demonstrates Verzenio win in high-risk breast cancer subset at ASCO

An exploratory analysis of a prespecified subgroup of patients with HR-positive/HER2-negative high-risk early breast cancer who had received neoadjuvant chemotherapy showed that the addition of Verzenio (abemaciclib)

Latest news

More from news
Approximately 7 fully matching, plus 27 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....